In a patient with ulcerative colitis who has intermittent pencil‑shaped stools, what functional causes should be considered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Functional Causes of Pencil-Shaped Stools in Ulcerative Colitis

In a UC patient with intermittent pencil-shaped stools and confirmed quiescent disease, the primary functional causes to consider are IBS-like symptoms with altered bowel motility, pelvic floor dysfunction/dyssynergic defecation, and bile acid diarrhea—each requiring specific evaluation and targeted management rather than escalation of IBD therapy.

Diagnostic Framework

Before attributing symptoms to functional causes, you must systematically exclude ongoing inflammatory activity and structural complications 1:

Rule Out Active Disease First

  • Measure fecal calprotectin as initial objective marker
  • Perform colonoscopy with biopsy if calprotectin elevated or symptoms persist
  • Obtain cross-sectional imaging (CT/MRI enterography) to exclude strictures, particularly in patients with obstructive-type symptoms 1

Exclude Structural Complications

Pencil-shaped stools specifically warrant evaluation for 1:

  • Luminal strictures (inflammatory or fibrotic)
  • Altered anatomy from prior surgery
  • Adhesions
  • Structural damage including "lead pipe" colon or fibrous bridges

Primary Functional Causes

Once inflammation and structural disease are excluded, consider these specific functional mechanisms 1:

1. IBS-Like Symptoms (IBD-IBS)

  • Occurs in approximately 30% of UC patients in remission 2
  • Characterized by symptoms disproportionate to objective inflammation
  • May manifest as altered bowel habits, including constipation-predominant patterns producing narrow stools
  • Driven by visceral hypersensitivity and altered gut-brain axis signaling

2. Pelvic Floor Dysfunction/Dyssynergic Defecation

  • Critical consideration for narrow stools specifically 1
  • Results from paradoxical contraction or inadequate relaxation of pelvic floor muscles during defecation
  • Can develop secondary to chronic straining or altered anorectal function from prior UC inflammation 3
  • Requires anorectal manometry for diagnosis
  • Treat with pelvic floor physical therapy 1

3. Bile Acid Diarrhea (BAD)

  • Evaluate based on predominant symptom pattern 1
  • Can paradoxically present with alternating diarrhea and constipation
  • Consider SeHCAT scan or empiric trial of bile acid sequestrants if available

4. Small Intestinal Bacterial Overgrowth (SIBO)

  • Evaluate with breath testing if symptoms include bloating, distension
  • More common in UC patients with prior surgery or altered motility 1

5. Carbohydrate Intolerance

  • Consider lactose or fructose malabsorption
  • Trial elimination or hydrogen breath testing 1

Key Clinical Pitfall

Do not escalate immunosuppressive therapy for functional symptoms in confirmed quiescent disease. This increases adverse effects without symptomatic benefit and represents overtreatment 1. The disconnect between symptoms and inflammation is well-documented in IBD, and approximately one-third of patients in objective remission report persistent IBS-like symptoms 2, 1.

Anorectal Dysfunction Considerations

Recent evidence demonstrates that inflammatory activity directly impairs anorectal function by increasing rectal sensitivity and reducing compliance 3. Importantly, anorectal dysfunction can persist even after achieving histological remission, suggesting functional alterations outlast inflammation. This is particularly relevant for narrow stools, as:

  • 49% of UC patients report anorectal functional disorders during long-term follow-up 4
  • Structural damage correlates with anorectal dysfunction (p < 0.001) 4
  • Altered rectal compliance and capacity contribute to symptom persistence 3

Management Algorithm

For confirmed functional causes 1:

For constipation-predominant symptoms producing narrow stools:

  • Osmotic laxatives (polyethylene glycol) or stimulant laxatives as first-line
  • Pelvic floor therapy if dyssynergic defecation confirmed (strongest recommendation)

For pain/cramping:

  • Antispasmodics, neuropathic agents (gabapentin, pregabalin), or low-dose antidepressants
  • Avoid opiates (increases dysfunction risk)

For persistent symptoms:

  • Low FODMAP diet trial (with nutritional monitoring)
  • Psychological therapies: cognitive behavioral therapy, gut-directed hypnotherapy, or mindfulness 1
  • Probiotics may be considered 1

Physical exercise should be encouraged for all functional GI symptoms in IBD 1.

Nuance on Terminology

The most recent consensus (2026) prefers the term "IBD with IBS-like symptoms" rather than "IBS-IBD overlap" 2. This emphasizes that symptoms are disproportionate to inflammation rather than representing two separate disease entities. The prevalence varies by remission criteria used (22-36%), being lower when stricter definitions (endoscopic/histologic healing) are applied 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.